Mangesh Tiwaskar, Prasun Deb, Rajesh Khadgawat, L Sreenivasamurthy, Nilakshi Deka, B Karthik, Ashwin Karuppan, Dipanjan Bhattacharjee, Viswanathan Mohan
Journal: The Journal of the Association of Physicians of India 2020;68(12[Special]):9-12
PMID: 33247657
Prior to the discovery of insulins, diabetes was managed predominantly by dietary interventions. Discovery of insulin and its first human trial highlighted the need for higher purity insulin thereby steering the subsequent journey of insulin development. Considering the limitations of the early preparations like short duration of action and need for several injections per day, attempts at protracting the duration of insulin action were made. This led to the development of intermediate-acting Neutral Protamine Hagedorn (NPH) and the Lente family of insulins. This review provides insights into the discovery of insulins and the shortcomings of early protracted release preparations, which in turn, gave impetus to the search for a 'true' basal insulin, which could mimic the endogenous human basal insulin secretion.
© Journal of the Association of Physicians of India 2011.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.